YAP1 and pulmonary fibrosis: We identify a previously unknown profibrotic mechanism, in which YAP expression does not only contribute to changes in the cellular phenotype of fibrotic AT2 cells but further drives the expression of the ECM crosslinking enzyme LOX leading to increased ECM/collagen formation and crosslinking in pulmonary fibrosis.